Glycopeptide profiling of beta-2-glycoprotein I by mass spectrometry reveals attenuated sialylation in patients with antiphospholipid syndrome

Journal of Proteomics

Volumn 73, Issue 1, 2009, Pages 123-133

  Kondo, Akira ^a   Miyamoto, Toshiaki ^b   Yonekawa, Osamu ^b   Giessing, Anders M ^a   Østerlund, Eva C ^a   Jensen, Ole N ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Seirei General Hospital   (Japan)

Author keywords

2 glycoprotein I; Antiphospholipid syndrome; In source decay; LC ESI MS; MALDI MS; N glycan

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; EPITOPE; GLYCAN; GLYCOPEPTIDE; SIALIC ACID;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGLYCOSYLATION; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIALYLATION; STRUCTURE ANALYSIS;

ADULT; ALGORITHMS; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CASE-CONTROL STUDIES; CHYMOTRYPSIN; DOWN-REGULATION; FEMALE; GLYCOPEPTIDES; GLYCOSYLATION; HUMANS; MALE; MASS SPECTROMETRY; MODELS, BIOLOGICAL; PEPTIDE MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIALIC ACIDS;

EID: 70349995796     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2009.08.007     Document Type: Article

References (28)

1. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
2. Schulze H.E., Heide H., and Haupt H. Über ein bisher unbekanntes niedermolekulares b2-globulin des humanserums. Naturwissenschaften 48 (1961) 719
3. Steinkasserer A., Estaller C., Weiss E.H., Sim R.B., and Day A.J. Complete nucleotide and deduced amino acid sequence of human β2-glycoprotein I. Biochem J 277 (1991) 387-391
4. Lozier J., Takahashi N., and Putnam F.W. Complete amino acid sequence of human plasma β2-glycoprotein I. Proc Natl Acad Sci USA 81 (1984) 3640-3644
5. McNeil H.P., Simpson R.J., Chesterman C.N., and Krilis S.A. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87 (1990) 4120-4124
6. Galli M., Comfurius P., Massen C., Hemker H.C., de Baets M.H., van Breda-Vriesman P.J., et al. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 335 (1990) 1544-1547
7. Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., and Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336 (1990) 177-178
8. Sheng Y., Kandiah D.A., and Krilis S.A. Anti-β2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to β2-glycoprotein I with low affinity: dimerization of β2-glycoprotein I induces a significant increase in anti-β2-glycoprotein I antibody affinity. J Immunol 161 (1998) 2038-2043
9. Matsuura E., Igarashi Y., Yasuda T., Triplett D.A., and Koike T. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen-modified solid phase surface. J Exp Med 179 (1994) 457-462
10. Kouts S., Wang M.X., Adelstein S., and Krilis S.A. Immunization of a rabbit with β2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies. J Immunol 155 (1995) 958-966
11. Igarashi M., Matsuura E., Igarashi Y., Nagae H., Ichikawa K., Triplett D.A., et al. Human β2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system. Blood 87 (1996) 3262-3270
12. George J., Gilburd B., Hojnik M., Levy Y., Langevitz P., Matsuura E., et al. Target recognition of β2-glycoprotein I (β2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of β2GPI in antibody binding. J Immunol 160 (1998) 3917-3923
13. McNeeley P.A., Dlott J.S., Furie R.A., Jack R.M., Ortel T.L., Triplett D.A., et al. β2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of β2-glycoprotein I. Thromb Haemost 86 (2001) 590-595
14. Shoenfeld Y., Krause I., Kvapil F., Sulkes J., Lev S., von Landenberg P., et al. Prevalence and clinical correlations of antibodies against six β2-glycoprotein-I-related peptides in the antiphospholipid syndrome. J Clin Immunol 23 (2003) 377-383
15. de Laat B., Derksen R.H., van Lummel M., Pennings M.T., and de Groot P.G. Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of β2-glycoprotein I only after a conformational change. Blood 107 (2006) 1916-1924
16. de Laat B., Derksen R.H., Urbanus R.T., and de Groot P.G. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 105 (2005) 1540-1545
17. Ioannou Y., Pericleous C., Giles I., Latchman D.S., Isenberg D.A., and Rahman A. Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis Rheum 56 (2007) 280-290
18. Hammel M., Kriechbaum M., Gries A., Kostner G.M., Laggner P., and Prassl R.J. Solution structure of human and bovine β2-glycoprotein I revealed by small-angle X-ray scattering. Mol Biol 321 (2002) 85-97
19. Walsh M.T., Watzlawick H., Putnam F.W., Schmid K., and Brossmer R. Effect of the carbohydrate moiety on the secondary structure of β2-glycoprotein I. Implications for the biosynthesis and folding of glycoproteins. Biochemistry 29 (1990) 6250-6257
20. Wada Y., Tajiri M., and Yoshida S. Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics. Anal Chem 76 (2004) 6560-6565
21. Jebanathirajah J., Steen H., and Roepstorff P. Using optimized collision energies and high resolution, high accuracy fragment ion selection to improve glycopeptide detection by precursor ion scanning. J Am Soc Mass Spectrom 14 (2003) 777-784
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
23. Larsen M.R., Højrup P., and Roepstorff P. Characterization of gel-separated glycoproteins using two-step proteolytic digestion combined with sequential microcolumns and mass spectrometry. Mol Cell Proteomics 4 (2005) 107-119
24. Hägglund P., Bunkenborg J., Elortza F., Jensen O.N., and Roepstorff P. A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J Proteome Res 3 (2004) 556-566
25. Thaysen-Andersen M., Thøgersen I.B., Nielsen H.J., Lademann U., Brünner N., Enghild J.J., et al. Rapid and individual-specific glycoprofiling of the low abundance N-glycosylated protein tissue inhibitor of metalloproteinases-1. Mol Cell Proteomics 6 (2007) 638-647
26. Wuhrer M., Stam J.C., van de Geijn F.E., Koeleman C.A., Verrips C.T., Dolhain R.J., et al. Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics 7 (2007) 4070-4081
27. Conboy J.J., and Henion J.D. The determination of glycopeptides by liquid chromatography/mass spectrometry with collision-induced dissociation. J Am Soc Mass Spectrom 3 (1992) 804-814
28. Huddleston M.J., Bean M.F., and Carr S.A. Collisional fragmentation of glycopeptides by electrospray ionization LC/MS and LC/MS/MS: methods for selective detection of glycopeptides in protein digests. Anal Chem 65 (1993) 877-884